Navigation Links
Mesa Labs Increases Quarterly Dividend
Date:11/12/2009

LAKEWOOD, Colo., Nov. 12 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: MLAB) today announced that its Board of Directors has declared a regular quarterly dividend of $.11 per share of common stock, up from $.10 per share last quarter. The dividend will be payable December 15, 2009, to shareholders of record on November 30, 2009.

Since going public in 1984 Mesa Labs has maintained strong cash positions and has continued to build its balance sheet through steady earnings growth. The increase in the regular quarterly dividend rate from $.10 to $.11 per common share represents a 10 percent increase from the previous dividend rate, and a 120 percent increase since initiation of the quarterly dividend policy in December 2003.

Mesa Laboratories develops, acquires, manufactures and markets electronic instruments and disposables for industrial, pharmaceutical and medical applications.

This news release contains forward-looking statements which involve risks and uncertainties. The Company's actual results could differ materially from those in any such forward-looking statements. Additional information concerning important factors that could cause results to differ materially from those in any such forward-looking statement is contained in the Company's Annual Report on Form-10KSB for the year ended March 31, 2009 as filed with the Securities and Exchange Commission, and from time to time in the Company's other reports on file with the Commission.

SOURCE Mesa Laboratories, Inc.


'/>"/>
SOURCE Mesa Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
2. Fat on chest and upper back increases risk of insulin resistance
3. Handling Stress Properly Increases Good Cholesterol
4. High alcohol consumption increases stroke risk among Chinese men
5. High alcohol consumption increases stroke risk, Tulane study says
6. Genetic predisposition increases childhood asthma risk
7. Smoking increases risks for head and neck cancers for men and women
8. Passive smoking increases sleep disturbance among pregnant women
9. Frequent alcohol consumption increases cancer risk in older women
10. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
11. Selective attention increases both gain and feature selectivity of the human auditory cortex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology: